TENX · Tenax Therapeutics, Inc.
Market Cap
$79.71M
Shares
37.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-10 | — | |
| 10-Q | 2026-07-31 | 2026-06-30 | |
| 8-K | 2026-07-31 | — | |
| 8-K | 2026-07-02 | — | |
| 8-K | 2026-06-30 | 2026-06-29 | |
| 8-K | 2026-06-29 | 2026-06-26 | |
| 8-K | 2026-06-04 | 2026-06-02 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-22 | 2026-04-17 | |
| 8-K | 2026-04-22 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-01-09 | 2026-01-06 | |
| 8-K | 2025-12-17 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-09-16 | — | |
| 8-K | 2025-09-09 | 2025-09-03 | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-06-17 | 2025-06-11 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-04-24 | |
| 10-K | 2025-03-25 | 2024-12-31 | |
| 8-K | 2025-03-25 | — | |
| 8-K | 2025-03-06 | 2025-03-04 | |
| 8-K | 2024-12-04 | 2024-12-02 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-10-30 | 2024-10-25 | |
| DEF 14A | 2024-09-27 | 2024-10-25 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-13 | 2024-06-07 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | — | |
| DEF 14A | 2024-04-26 | 2024-06-07 | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-03-28 | — | |
| 8-K | 2024-02-23 | 2024-02-22 | |
| 8-K | 2024-02-20 | 2024-02-19 | |
| 8-K | 2024-02-12 | 2024-02-08 | |
| 8-K | 2024-02-08 | 2024-02-07 | |
| 8-K | 2024-02-06 | — | |
| 8-K | 2024-01-19 | 2024-01-18 | |
| 8-K | 2024-01-12 | 2024-01-09 |
Showing 1–50 of 123 filings
Key facts
CIK
34956
CUSIP
88032L605
13F (30d)
119 filings
113 filers
Visit website
Investor relations